Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stefan H Hohnloser
Effects of Apixaban Compared With Warfarin as Gain in Event-Free Time – A Novel Assessment of the Results of the ARISTOTLE Trial
European Journal of Preventive Cardiology
Epidemiology
Cardiovascular Medicine
Cardiology
Prevention of Sudden Cardiac Death
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Related publications
The Cost-Effectiveness of Apixaban Compared to Warfarin, Aspirin, Rivaroxaban and Dabigatran in Ireland
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Efficacy and Safety of Apixaban Versus Warfarin Are Preserved in Patients With Atrial Fibrillation and Extreme Body Weight: Insights From the Aristotle Study
Canadian Journal of Cardiology
Cardiovascular Medicine
Cardiology
Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin
Circulation. Cardiovascular quality and outcomes
Medicine
Cardiovascular Medicine
Cardiology
Cost-Effectiveness of Apixaban Compared to Other Anticoagulants in Patients With Atrial Fibrillation in the Real-World and Trial Settings
PLoS ONE
Multidisciplinary
High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Assessment of the Anticoagulation Activity of Apixaban – Reply –
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
Dabigatran Compared With Rivaroxaban vs Warfarin
JAMA Internal Medicine
Internal Medicine
Response to Letters Regarding Article, "Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial"
Circulation
Cardiovascular Medicine
Physiology
Cardiology
